A citation-based method for searching scientific literature

Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver, Sarah H Lockie, David L Smiley, Vasily Gelfanov, Bin Yang, Susanna Hofmann, Dennis Bruemmer, Daniel J Drucker, Paul T Pfluger, Diego Perez-Tilve, Jaswant Gidda, Louis Vignati, Lianshan Zhang, Jonathan B Hauptman, Michele Lau, Mathieu Brecheisen, Sabine Uhles, William Riboulet, Emmanuelle Hainaut, Elena Sebokova, Karin Conde-Knape, Anish Konkar, Richard D DiMarchi, Matthias H Tschöp. Sci Transl Med 2013
Times Cited: 326



John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F Kushner. N Engl J Med 2021
Times Cited: 388




List of shared articles



Times cited

Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands.
Neil Tanday, Peter R Flatt, Nigel Irwin. Br J Pharmacol 2022
7

Gut peptide regulation of food intake - evidence for the modulation of hedonic feeding.
Orla R M Woodward, Fiona M Gribble, Frank Reimann, Jo E Lewis. J Physiol 2022
4

Anti-obesity drug discovery: advances and challenges.
Timo D Müller, Matthias Blüher, Matthias H Tschöp, Richard D DiMarchi. Nat Rev Drug Discov 2022
53

The emerging role of incretins and twincretins.
Elaine Chow, Juliana C N Chan. Nat Rev Endocrinol 2022
1

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.
Qiming Tan, Seun E Akindehin, Camila E Orsso, Richelle C Waldner, Richard D DiMarchi, Timo D Müller, Andrea M Haqq. Front Endocrinol (Lausanne) 2022
9


Targeting the Enteroendocrine System for Treatment of Obesity.
Emily L Miedzybrodzka, Fiona M Gribble, Frank Reimann. Handb Exp Pharmacol 2022
0

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice.
Patrick J Knerr, Stephanie A Mowery, Jonathan D Douros, Bhavesh Premdjee, Karina Rahr Hjøllund, Yantao He, Ann Maria Kruse Hansen, Anette K Olsen, Diego Perez-Tilve, Richard D DiMarchi,[...]. Mol Metab 2022
1

Signaling pathways in obesity: mechanisms and therapeutic interventions.
Xue Wen, Bohan Zhang, Beiyi Wu, Haitao Xiao, Zehua Li, Ruoyu Li, Xuewen Xu, Tao Li. Signal Transduct Target Ther 2022
1


GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders.
Ricardo J Samms, Kyle W Sloop, Fiona M Gribble, Frank Reimann, Alice E Adriaenssens. Diabetes 2021
7

Reagents and models for detecting endogenous GLP1R and GIPR.
Julia Ast, Johannes Broichhagen, David J Hodson. EBioMedicine 2021
4

Glucagon-Like Peptide-1 Receptor Agonists-Use in Clinical Practice.
Domenico Tricò, Anna Solini. Adv Chronic Kidney Dis 2021
0